Dr. Jacob Zeitani earned his degree in Medicine and Surgery from the University of La Sapienza in Rome in 1993 and completed his Cardiac Surgery specialization at the University of Rome "Tor Vergata" in 2000 with full honors. He spent a year at the St. Antonius Hospital in the Netherlands, a top-tier center for cardiac surgery, where he developed a strong reputation. Dr. Zeitani performed over 2,000 surgeries, including emergency procedures for aortic and cardiac pathologies, and led several research projects, including the development of a sternum synthesis device, which gained CE and FDA approvals. He holds patents for his inventions and has authored several published works cited over 100 times. He also coordinated a study on extracorporeal circulation machines, which was presented at the EACTS congress. His deep interest in aortic pathologies has led to innovations in vascular devices, including one for aortic arch surgeries. Additionally, Dr. Zeitani developed a hybrid prosthesis for treating thoraco-abdominal aortic diseases. His research has earned him recognition internationally, with collaborations in Israel, Europe, and Ecuador. As a faculty member at the University of Rome Tor Vergata and the University of Ferrara, he also teaches and mentors students in cardiovascular pathologies. He continues to innovate, particularly in the development of a mitral valve device and hybrid aortic endoprostheses, while focusing on advancing treatments for Marfan syndrome and aortic